The market size of CRISPR genome editing in South Korea was forecasted to increase to 70 million U.S. dollars in 2020 from six million U.S. dollars in 2014. CRISPR stands for "clustered regularly interspaced short palindromic repeats" and is a family of DNA sequences.
Market size of CRISPR genome editing in South Korea in 2014 and a forecast for 2020 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Premium Statistic Top owners of CRISPR patents worldwide 2019
- Premium Statistic Total number of CRISPR patent applications worldwide 1984-2018
- Premium Statistic Number of CRISPR patent applications globally by industry sector 2018
- Premium Statistic Top countries by number of CRISPR patent applications 2019
- Premium Statistic Patent expiration risks for total worldwide prescription drug revenue 2023-2028
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic Projection of global revenue for orphan prescription drugs 2016-2028
- Basic Statistic Number of patent applications filed for top U.S. drugs 2022
- Premium Statistic Number of cumulative orphan designations accepted in the U.S. 2003-2018
About the region
10
- Premium Statistic CRISPR-Cas gene market size projections globally 2023 vs 2033
- Basic Statistic Whole exome sequencing market revenues worldwide 2018-2027
- Basic Statistic Amgen's expenditure on research and development by category 2012-2023
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Premium Statistic Top pharmaceutical R&D projects based on net present value August 2023
- Basic Statistic Percentage return on R&D among mid cap biopharma companies 2013-2020
- Basic Statistic 3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
- Basic Statistic Global biotech prescription drug market share - top 10 companies 2019 and 2026
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Premium Statistic Global AI-enabled drug discovery and clinical trials market by region 2030
Selected statistics
6
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
9
- Basic Statistic Number of biotechnology patents in Denmark 2011-2020
- Basic Statistic Value of top European biotech IPOs in 2022
- Premium Statistic Value of top U.S. biotech IPOs 2022
- Basic Statistic Number of biotechnology patents in Norway 2011-2020
- Basic Statistic Employment in California's life science industry in 2022, by sector
- Basic Statistic Swiss biotech companies: profit 2016-2023
- Premium Statistic Percentage distribution of turnover of biotech enterprises in Spain 2020, by region
- Premium Statistic Biopharmaceuticals: new registrations share in Germany 2000-2022
- Premium Statistic Oncology medicines sales in Canada 2010-2019
Related statistics
10
- Premium Statistic Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Premium Statistic Biopharmaceutical production value in South Korea 2012-2022
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Changes in outpatient prescriptions in Gyeonggi/Incheon/Gangwon South Korea 2020
- Premium Statistic Impact of COVID-19 on OTC pharmacy sales South Korea 2020
- Premium Statistic Changes in outpatient prescriptions during COVID-19 in Seoul South Korea 2020
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- GSK's operating profit by division 2006-2021
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
- Johnson & Johnson's number of employees 2004-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- GSK's operating profit by division 2006-2021
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
- Johnson & Johnson's number of employees 2004-2023
Seoul Economic Daily. (November 10, 2017). Market size of CRISPR genome editing in South Korea in 2014 and a forecast for 2020 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 10, 2024, from https://www.statista.com/statistics/1173559/south-korea-crispr-genome-editing-market-size/
Seoul Economic Daily. "Market size of CRISPR genome editing in South Korea in 2014 and a forecast for 2020 (in million U.S. dollars)." Chart. November 10, 2017. Statista. Accessed May 10, 2024. https://www.statista.com/statistics/1173559/south-korea-crispr-genome-editing-market-size/
Seoul Economic Daily. (2017). Market size of CRISPR genome editing in South Korea in 2014 and a forecast for 2020 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 10, 2024. https://www.statista.com/statistics/1173559/south-korea-crispr-genome-editing-market-size/
Seoul Economic Daily. "Market Size of Crispr Genome Editing in South Korea in 2014 and a Forecast for 2020 (in Million U.S. Dollars)." Statista, Statista Inc., 10 Nov 2017, https://www.statista.com/statistics/1173559/south-korea-crispr-genome-editing-market-size/
Seoul Economic Daily, Market size of CRISPR genome editing in South Korea in 2014 and a forecast for 2020 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1173559/south-korea-crispr-genome-editing-market-size/ (last visited May 10, 2024)
Market size of CRISPR genome editing in South Korea in 2014 and a forecast for 2020 (in million U.S. dollars) [Graph], Seoul Economic Daily, November 10, 2017. [Online]. Available: https://www.statista.com/statistics/1173559/south-korea-crispr-genome-editing-market-size/